KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Debt to Equity: 2009-2024

Historic Debt to Equity for Exact Sciences (EXAS) over the last 13 years, with Mar 2024 value amounting to $0.02.

  • Exact Sciences' Debt to Equity fell 2.39% to $0.02 in Q1 2024 from the same period last year, while for Mar 2024 it was $0.02, marking a year-over-year decrease of 2.39%. This contributed to the annual value of $0.02 for FY2023, which is 3.25% down from last year.
  • Per Exact Sciences' latest filing, its Debt to Equity stood at $0.02 for Q1 2024, which was up 0.40% from $0.02 recorded in Q4 2023.
  • Exact Sciences' Debt to Equity's 5-year high stood at $0.02 during Q4 2022, with a 5-year trough of $0.01 in Q1 2021.
  • Its 3-year average for Debt to Equity is $0.02, with a median of $0.02 in 2022.
  • Its Debt to Equity has fluctuated over the past 5 years, first crashed by 97.92% in 2020, then spiked by 159.41% in 2022.
  • Exact Sciences' Debt to Equity (Quarterly) stood at $0.01 in 2020, then crashed by 36.00% to $0.01 in 2021, then spiked by 159.41% to $0.02 in 2022, then declined by 3.25% to $0.02 in 2023, then fell by 2.39% to $0.02 in 2024.
  • Its last three reported values are $0.02 in Q1 2024, $0.02 for Q4 2023, and $0.02 during Q3 2023.